Figure S3.
Comparisons of neoantigen counts and percentage among different groups. (A) Neoantigens counts of primary lesions in different groups, e.g., LM vs. BM; male vs. female; smoking vs. non-smoking; and LUAD vs. non-LUAD. (B) Neoantigens counts of metastases in different groups similar to A. LUAD, lung adenocarcinoma; LM, liver metastasis; BM, brain metastasis.